Startseite Kongressberichte 2021 ESMO 2014, Madrid 26 - 30 September 2014 Anti-EGFR or anti-VEGF in first-line RAS wild-type metastastic CRC patients Interview with PD Dr. med. Gunnar Folprecht, Universitätsklinikum Carl Gustav Carus, Dresden

Comments on CALGB/SWOG 80405 & FIRE-3

Interview with PD Dr. med. Gunnar Folprecht, Universitätsklinikum Carl Gustav Carus, Dresden: